Glenmark Pharmaceuticals receives ANDA approval for Clobetasol Propionate Foam
MUMBAI, INDIA: Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Clobetasol Propionate Foam, 0.05% (Emulsion Formulation), a generic version of Olux®1‐E Foam, 0.05%, of Mylan Pharmaceuticals Inc. According…